Metcalf CA, Cross H, Dillon BA, Douglas JM, Malotte CK, Young PA, Lindsey CA, Peterman TA; International Conference on AIDS.

Int Conf AIDS. 2002 Jul 7-12; 14: abstract no. MoOrD1019.

Centers for Disease Control and Prevention, Atlanta, United States

BACKGROUND: Project RESPECT found that HIV testing with 2 sessions of prevention counseling can prevent more sexually transmitted diseases (STDs) than HIV testing with information alone. In practice, many patients do not return for their HIV test result and 2nd counseling session. We compared rapid HIV testing with all counseling at the same visit with standard HIV testing and 2 counseling sessions 1 week apart for efficacy at preventing STDs. METHODS: Consenting STD clinic patients in 3 US cities were randomized to receive either a rapid or standard HIV test. Participants were interviewed and screened for chlamydia, gonorrhea, and trichomoniasis at baseline and every 3 months for 1 year, and were screened for HIV and syphilis at baseline and 12 months. We did an intention to treat analysis. RESULTS: 3,293 participants were enrolled and followed-up for 12 months. Data are pending for 14.2% of participants. Over 95% of the rapid test group received their test result. 67.7% of the standard test group returned for the test result and 2nd session. Preliminary data show 22% more new STDs by the 6-month visit in the rapid test group (12.6%) compared to the standard test group (10.3%) (relative risk [RR] 1.22; 95% confidence interval [CI] 1.01-1.48; p=0.04). By the 12-month visit, there were 12% more new STDs since baseline in the rapid test group (18.8%) compared to the standard test group (16.9%) (RR 1.12; CI 0.96-1.29; p=0.14). CONCLUSIONS: More patients receive their HIV test result using a rapid HIV test than a standard HIV test. However, preliminary results indicate that the standard 2-visit counseling was associated with fewer new STDs. This difference in STD rates between groups decreased over time.

Publication Types:

• Meeting Abstracts

Keywords:

• Acquired Immunodeficiency Syndrome
• Ambulatory Care Facilities
• Clinical Trials as Topic
• Counseling
• Gonorrhea
• HIV Infections
• HIV Seropositivity
• Humans
• Sexually Transmitted Diseases

Other ID:

• GWAIDS0015177

UI: 102252675

From Meeting Abstracts